I recently told you about rectal chelation helping your prostate. While the rectal suppository can work wonders, theres a way to enhance its abilities. This help comes from another unexpected source.
A new study compared the intake of phylloquinone (vitamin K1), menaquinones (vitamin K2), and prostate cancer. The data was gathered from a food frequency questionnaire among 11,319 men in Europe. The men were followed for 8.6 years.
The researchers found that the higher the vitamin K2 intake, the lower the risk of mild, moderate, and advanced prostate cancer (total cancers). But, this risk appeared to be non-significant. However, where the vitamin K2 seemed to make the most difference was in the development of advanced prostate cancer. Vitamin K2 intake was associated with a strong 63% reduction in risk of advanced prostate cancer. Vitamin K1 intake was unrelated to prostate cancer incidence.
I have seen research suggesting that vitamin K2 helps prevent and/or treat liver cancer. Now its linked to sparing your prostate. Why? One explanation might be calcium metabolism. Vitamin K2 helps keep calcium in your bones and out of soft tissues. (It is a major player in preventing calcification of your blood vessels).
In my Detoxamin article, I told you how men with prostate disease accumulate calcium in the gland. Its similar to the calcifications women get with breast cancer. If we can keep these abnormal calcium metabolic processes from happening, we might prevent cancer.
I will have a detailed report on the wonders of vitamin K2 in an upcoming issue. This nutrient is a product of bacterial fermentation, whether in natto, cheese, or natural fermentation in your intestinal tract.
If you have access to natto, do not hesitate to eat it. Its loaded with nattokinase and extremely rich in vitamin K2. Far inferior sources are fermented dairy products and egg yolks. Of course, vitamin K2 is now being added to superior nutritional supplements.
Ref: Nimptsch, K., S. Rohrmann, and J. Linseisen. Dietary Intake of Vitamin K and Risk of Prostate Cancer in the Heidelberg Cohort of the European Prospective Investigation into Cancer and Nutrition